Compare

Danone/€BN

1D1W1M3M6MYTD1Y5YMAX

About Danone

Danone is a multinational food-products corporation headquartered in Paris, France. The company operates primarily in the food and beverage industry, focusing on fresh dairy products, plant-based foods and beverages, water, and specialized nutrition. Its key segments include Essential Dairy and Plant-Based Products, Waters, and Specialized Nutrition, catering to both general consumer and medical nutrition needs. Founded in 1919 in Barcelona, Danone has grown to establish a significant presence across Europe, Asia, and the Americas. The company emphasizes its commitment to health and sustainability, differentiating itself through its focus on nutritious and environmentally friendly offerings.
Ticker
€BN
Primary listing
PAR
Employees
88,670
Headquarters
Paris, France

Danone Metrics

BasicAdvanced
€45B
23.12
€3.02
0.19
€2.25
3.22%

What the Analysts think about Danone

Analyst ratings (Buy, Hold, Sell) for Danone stock.
Analyst projections of the future price of Danone stock.

Bulls say / Bears say

Third-quarter like-for-like sales grew 4.0%, ahead of the 3.7% consensus, and Danone kept its 2026 growth target while expecting recurring operating income to grow faster than sales. That supports confidence in near-term delivery. (Reuters)
Specialised Nutrition grew 4.7% in the third quarter, with Danone reporting sustained demand across regions. This gives the group a solid growth engine in health-focused products. (Danone)
First-half recurring operating margin rose 12 basis points to 13.3%, while free cash flow reached €852 million. Productivity gains helped offset inflation and recall-related pressure, showing resilience in profitability and cash generation. (Danone)
Third-quarter sales growth relied heavily on pricing: prices added 3.6 percentage points, while volume and mix rose just 0.4%. If customers resist further increases, that weak underlying volume growth could make targets harder to deliver. (Reuters)
North American sales grew only 2.4% in the third quarter, with volume and mix down 0.6%; Danone said it is taking further action to restore momentum in its dairy and plant-based business. This points to continuing execution and competitiveness problems in a key market. (Danone)
The infant-formula recall remains a trust and regulatory overhang: Reuters reported fresh scrutiny of recall handling, while Danone said the specialised-nutrition recovery in Europe is still gradual. Rebuilding confidence could therefore take time. (Reuters, Danone)
Data summarised monthly by Lightyear AI. Last updated on 28 Oct 2026.

Danone Financial Performance

Revenues and expenses
Income statement
AnnuallyQuarterly
2023
YoY growth
Revenue
Net income
Profit margin

Danone Earnings Performance

Company profitability
Earnings per share
AnnuallyQuarterly
2020
2021
2022
2023
2024
Actual
Expected
Surprise

Funds containing Danone

AllEURUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.